 those with CLTI, as suggested
by the GVG, ESVM, and ESC-EASD guidelines and the
2023 ADA Standards of Care.16,20,23,129 This suggestion is
based on the COMPASS trial in which this combination
therapy was more effective than aspirin but was also
associated with an increased risk of clinically relevant
bleeding, mostly gastrointestinal.136 In this trial approximately 38% had diabetes